IL104289A0 - Process and uses for 4,5-dihydrogel-danamycin and its hydroquinone - Google Patents

Process and uses for 4,5-dihydrogel-danamycin and its hydroquinone

Info

Publication number
IL104289A0
IL104289A0 IL104289A IL10428992A IL104289A0 IL 104289 A0 IL104289 A0 IL 104289A0 IL 104289 A IL104289 A IL 104289A IL 10428992 A IL10428992 A IL 10428992A IL 104289 A0 IL104289 A0 IL 104289A0
Authority
IL
Israel
Prior art keywords
dihydrogel
danamycin
hydroquinone
Prior art date
Application number
IL104289A
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL104289A0 publication Critical patent/IL104289A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
IL104289A 1992-01-06 1992-12-31 Process and uses for 4,5-dihydrogel-danamycin and its hydroquinone IL104289A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81723592A 1992-01-06 1992-01-06

Publications (1)

Publication Number Publication Date
IL104289A0 true IL104289A0 (en) 1993-05-13

Family

ID=25222638

Family Applications (1)

Application Number Title Priority Date Filing Date
IL104289A IL104289A0 (en) 1992-01-06 1992-12-31 Process and uses for 4,5-dihydrogel-danamycin and its hydroquinone

Country Status (15)

Country Link
JP (1) JPH06510913A (en)
KR (1) KR940703923A (en)
CN (1) CN1074937A (en)
AU (1) AU3225693A (en)
BR (1) BR9207024A (en)
CA (1) CA2127457A1 (en)
CZ (1) CZ390592A3 (en)
FI (1) FI943207A0 (en)
HU (1) HU9401936D0 (en)
IL (1) IL104289A0 (en)
MX (1) MX9300011A (en)
NO (1) NO942532D0 (en)
PT (1) PT101169A (en)
WO (1) WO1993014215A1 (en)
ZA (1) ZA9333B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2794342B2 (en) * 1993-06-29 1998-09-03 ファイザー・インク． Ansamycin derivatives as anticancer gene agents and anticancer agents
US5932566A (en) * 1994-06-16 1999-08-03 Pfizer Inc. Ansamycin derivatives as antioncogene and anticancer agents
US6852496B1 (en) 1997-08-12 2005-02-08 Oregon Health And Science University Methods of screening for agents that promote nerve cell growth
US6872715B2 (en) * 2001-08-06 2005-03-29 Kosan Biosciences, Inc. Benzoquinone ansamycins
EP1923061A1 (en) 2001-09-24 2008-05-21 Conforma Therapeutic Corporation Process for preparing 17-Allyl amino geldanamycin (17-AAG) and other ansamycins
CN100378079C (en) 2001-09-24 2008-04-02 康福玛医药公司 Process for preparing 17-allyl amino geldanamycin (17-AAG) and other ansamycins
AU2003217393B8 (en) 2002-02-08 2009-06-25 Conforma Therapeutics Corporation Ansamycins having improved pharmacological and biological properties
TW200303363A (en) * 2002-02-25 2003-09-01 Upjohn Co Process to prepare and isolate geldanamycin
WO2005009345A2 (en) 2003-06-13 2005-02-03 Kosan Biosciences, Inc. 2-desmethyl ansamycin compounds
US6875863B1 (en) 2003-11-12 2005-04-05 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6870049B1 (en) 2003-11-12 2005-03-22 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6887993B1 (en) 2003-11-12 2005-05-03 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6855705B1 (en) 2003-11-12 2005-02-15 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
JP2007512369A (en) * 2003-11-26 2007-05-17 エンテロス・インコーポレーテッド Treatment of rheumatoid arthritis with hypoxia-inducible factor 1α antagonist
CN1898212B (en) * 2003-12-23 2012-06-13 无限发现公司 Analogs of benzoquinone-containing ansamycins for the treatment of cancer
US20060019941A1 (en) * 2003-12-23 2006-01-26 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
ES2409351T3 (en) 2003-12-23 2013-06-26 Infinity Discovery, Inc. Ansamycin analogs containing benzoquinone for cancer treatment
NZ561939A (en) 2005-03-30 2011-03-31 Conforma Therapeutics Corp Alkynyl pyrrolopyrimidines and related analogs as HSP90-inhibitors
JP2010509306A (en) * 2006-11-09 2010-03-25 バイオチカ テクノロジー リミテッド Novel compounds and methods for producing them
PE20081506A1 (en) 2006-12-12 2008-12-09 Infinity Discovery Inc ANSAMYCIN FORMULATIONS
CN100500668C (en) * 2006-12-19 2009-06-17 中国人民解放军军事医学科学院毒物药物研究所 Geldanamycin derivative and its preparing method and use for preparing medicine
WO2008094438A1 (en) 2007-01-26 2008-08-07 Kosan Biosciences Incorporated Macrolactams by engineered biosynthesis
US20110034686A1 (en) * 2008-04-21 2011-02-10 Nitin Sopanrao Patil Process for Isolation and Purification of Geldanamycin
KR20110090925A (en) 2008-10-15 2011-08-10 인피니티 파마슈티컬스, 인코포레이티드 Ansamycin hydroquinone compositions
CN102030764B (en) * 2010-11-12 2012-07-04 中国医学科学院医药生物技术研究所 4,5-dihydro-thiazinogeldanamycin and preparation method thereof
CN103305563B (en) * 2013-06-14 2014-12-03 湖南农业大学 Method for extracting alisamycin from streptomyces

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3595955A (en) * 1969-03-26 1971-07-27 Upjohn Co Geldanamycin and process for producing same

Also Published As

Publication number Publication date
CZ390592A3 (en) 1993-08-11
JPH06510913A (en) 1994-12-08
KR940703923A (en) 1994-12-12
AU3225693A (en) 1993-08-03
HU9401936D0 (en) 1994-09-28
MX9300011A (en) 1993-12-01
BR9207024A (en) 1995-12-05
NO942532L (en) 1994-07-05
FI943207A (en) 1994-07-05
FI943207A0 (en) 1994-07-05
CN1074937A (en) 1993-08-04
ZA9333B (en) 1994-07-05
CA2127457A1 (en) 1993-07-22
NO942532D0 (en) 1994-07-05
PT101169A (en) 1994-03-31
WO1993014215A1 (en) 1993-07-22

Similar Documents

Publication Publication Date Title
HU9401936D0 (en) Process and uses for 4,5-diohydrogeldanamycin and its hydroquinone
EP0589675A3 (en) BiCDMOS process technology and structures.
ZA938826B (en) Process
GB9218346D0 (en) Process
GB9203375D0 (en) Process
KR970000398B1 (en) Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane
SG73396A1 (en) Hydrotrating process
GB9202375D0 (en) Process
IL105168A0 (en) Heteroannulation process
AP9300474A0 (en) Process
GB9220068D0 (en) Process
ZA939517B (en) Process
GB9301275D0 (en) Process
GB9215438D0 (en) Process
AP9300473A0 (en) Process
GB9220526D0 (en) Process
GB9301562D0 (en) Process
GB9225202D0 (en) Process
GB9225373D0 (en) Novel compounds and process
GB9216664D0 (en) Novel compounds and process
GB9216662D0 (en) Novel compounds and process
GB9204277D0 (en) Process
GB9201230D0 (en) Process
GB9221672D0 (en) Process
GB9224647D0 (en) Process